Cite
HARVARD Citation
Nocturne, G. et al. (n.d.). P028 Treatment of BAFF transgenic mice with ANTI-TNF: monoclonal ANTI-TNF are associated with a higher risk of lymphoma than etanercept. Annals of the rheumatic diseases. pp. A25-A26. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nocturne, G. et al. (n.d.). P028 Treatment of BAFF transgenic mice with ANTI-TNF: monoclonal ANTI-TNF are associated with a higher risk of lymphoma than etanercept. Annals of the rheumatic diseases. pp. A25-A26. [Online].